We then assessed whether MEK1/2 inhibition would result in reduced secretion of inflammatory cytokines by PD astrocytes and observed that PD0325901 treatment significantly down-regulated IL-8 release in ACM prepared from isogenic or non-isogenic (Fig. 5G) cultures. Here, MAP2K1 is linked to Parkinson disease.